AquaBounty Technologies, Inc. (NASDAQ:AQB) Sees Significant Growth in Short Interest

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a large growth in short interest in the month of October. As of October 15th, there was short interest totalling 96,200 shares, a growth of 7.2% from the September 30th total of 89,700 shares. Currently, 2.7% of the shares of the stock are short sold. Based on an average daily trading volume, of 29,200 shares, the days-to-cover ratio is presently 3.3 days.

AquaBounty Technologies Trading Up 2.0 %

Shares of AQB stock opened at $1.19 on Thursday. The business’s fifty day moving average price is $1.11 and its 200 day moving average price is $1.49. The firm has a market capitalization of $4.59 million, a PE ratio of -0.14 and a beta of 1.15. The company has a debt-to-equity ratio of 0.05, a current ratio of 1.96 and a quick ratio of 1.96. AquaBounty Technologies has a 1-year low of $0.81 and a 1-year high of $4.03.

AquaBounty Technologies (NASDAQ:AQB) last issued its earnings results on Tuesday, August 6th. The company reported ($1.56) EPS for the quarter, missing the consensus estimate of ($0.93) by ($0.63). The company had revenue of $0.18 million for the quarter, compared to analysts’ expectations of $0.10 million. AquaBounty Technologies had a negative return on equity of 17.81% and a negative net margin of 3,923.57%. As a group, sell-side analysts forecast that AquaBounty Technologies will post -4.86 EPS for the current fiscal year.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.